Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $41.9B |
| FY2017, ended Dec 31, 2017 | $48.4B |
| FY2018, ended Dec 31, 2018 | $35.4B |
| FY2019, ended Dec 31, 2019 | $47.0B |
| FY2020, ended Dec 31, 2020 | $45.4B |
| FY2021, ended Dec 31, 2021 | $60.0B |
| FY2022, ended Dec 31, 2022 | $35.4B |
| FY2023, ended Dec 31, 2023 | $49.9B |
| FY2024, ended Dec 31, 2024 | $68.0B |
| FY2025, ended Dec 31, 2025 | $151B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $123B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.5B |
| FY2017, ended Dec 31, 2017 | $27.2B |
| FY2018, ended Dec 31, 2018 | $28.1B |
| FY2019, ended Dec 31, 2019 | $28.6B |
| FY2020, ended Dec 31, 2020 | $28.5B |
| FY2021, ended Dec 31, 2021 | $30.4B |
| FY2022, ended Dec 31, 2022 | $34.3B |
| FY2023, ended Dec 31, 2023 | $36.8B |
| FY2024, ended Dec 31, 2024 | $39.1B |
| FY2025, ended Dec 31, 2025 | $53.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $62.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.75B | $11.1B |
| FY2017, ended Dec 31, 2017 | $1.98B | $13.2B |
| FY2018, ended Dec 31, 2018 | $6.01B | $12.1B |
| FY2019, ended Dec 31, 2019 | $5.55B | $15.8B |
| FY2020, ended Dec 31, 2020 | $2.71B | $16.0B |
| FY2021, ended Dec 31, 2021 | $12.4B | $11.6B |
| FY2022, ended Dec 31, 2022 | $7.36B | $12.9B |
| FY2023, ended Dec 31, 2023 | $4.89B | $19.6B |
| FY2024, ended Dec 31, 2024 | $4.75B | $17.0B |
| FY2025, ended Dec 31, 2025 | $2.45B | $26.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.5B | $29.7B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $12.5B |
| FY2017, ended Dec 31, 2017 | $14.4B |
| FY2018, ended Dec 31, 2018 | $13.5B |
| FY2019, ended Dec 31, 2019 | $13.7B |
| FY2020, ended Dec 31, 2020 | $40.8B |
| FY2021, ended Dec 31, 2021 | $22.1B |
| FY2022, ended Dec 31, 2022 | $31.3B |
| FY2023, ended Dec 31, 2023 | $43.8B |
| FY2024, ended Dec 31, 2024 | $43.7B |
| FY2025, ended Dec 31, 2025 | $62.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $55.9B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $60.5B |
| FY2017, ended Dec 31, 2017 | $60.3B |
| FY2018, ended Dec 31, 2018 | $58.9B |
| FY2019, ended Dec 31, 2019 | $55.7B |
| FY2020, ended Dec 31, 2020 | $40.5B |
| FY2021, ended Dec 31, 2021 | $43.1B |
| FY2022, ended Dec 31, 2022 | $48.7B |
| FY2023, ended Dec 31, 2023 | $49.9B |
| FY2024, ended Dec 31, 2024 | $45.6B |
| FY2025, ended Dec 31, 2025 | $51.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $45.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 27.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 481M |
| FY2017, ended Dec 31, 2017 | 486M |
| FY2018, ended Dec 31, 2018 | 468M |
| FY2019, ended Dec 31, 2019 | 457M |
| FY2020, ended Dec 31, 2020 | 459M |
| FY2021, ended Dec 31, 2021 | 414M |
| FY2022, ended Dec 31, 2022 | 381M |
| FY2023, ended Dec 31, 2023 | 380M |
| FY2024, ended Dec 31, 2024 | 381M |
| FY2025, ended Dec 31, 2025 | 622M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 613M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.66B | $239M | $131M |
| FY2017, ended Dec 31, 2017 | $240M | $244M | $164M |
| FY2018, ended Dec 31, 2018 | $2.28B | $170M | $175M |
| FY2019, ended Dec 31, 2019 | $1.48B | $239M | $199M |
| FY2020, ended Dec 31, 2020 | $393M | $203M | $241M |
| FY2021, ended Dec 31, 2021 | $7.61B | $331M | $253M |
| FY2022, ended Dec 31, 2022 | $4.95B | $314M | $276M |
| FY2023, ended Dec 31, 2023 | $718M | $513M | $299M |
| FY2024, ended Dec 31, 2024 | $734M | $569M | $323M |
| FY2025, ended Dec 31, 2025 | $4.10B | $776M | $400M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $9.10B | $720M | $454M |
Valuation
At current price- Market Cap
- $125B
- P/E
- 11.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.0×
- Price / Book
- 1.1×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $62.0B
- Revenue Growth YoY
- 45.3%
- Revenue CAGR 3Y
- 16.0%
- Revenue CAGR 5Y
- 13.4%
- EPS Growth YoY
- 5,441%
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 17.0%
- FCF Margin
- 47.9%
- Return on Equity
- 9.4%
Earnings
Trailing 12 months- Net Income
- $10.5B
- EPS (diluted)
- $18.84
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $55.9B
- Total Debt
- $45.4B
- Net Cash
- $10.5B
- Total Assets
- $674B
- Total Liabilities
- $560B
- Shareholders' Equity
- $114B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $31.5B
- Capital Expenditure
- $1.75B
- Free Cash Flow
- $29.7B
Dividends and risk
Last 12 months- Dividend Yield
- 1.6%
- Dividend / Share
- $3.20
- Beta (5Y)
- 1.04
Every ratio is calculated from the company’s reported figures.